dc.contributor.author | Örün, Serhat | |
dc.contributor.author | Erdem, Mustafa Numan | |
dc.date.accessioned | 2022-05-11T14:37:02Z | |
dc.date.available | 2022-05-11T14:37:02Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 2050-3121 | |
dc.identifier.uri | https://doi.org/10.1177/20503121211046416 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/8539 | |
dc.description.abstract | Background: 6.5% of the country's population was diagnosed with COVID-19 disease. Computed tomography scanning and polymerase chain reaction tests are considered reliable methods for the detection of COVID-19. However, the specificity and reliability of polymerase chain reaction tests and ground-glass opacity (GGO) on thorax computed tomography images in diagnosing COVID-19 are still being disputed. Our aim was to compare the neutrophil/lymphocyte ratio, whose efficiency in differentiating between viral and bacterial infections has previously been studied, with computed tomography and polymerase chain reaction for COVID-19 diagnosis. Materials and methods: This was a retrospective study that included patients treated in a tertiary care hospital emergency service pandemic polyclinic between 14 March and 1 June 2020. The neutrophil/lymphocyte ratios of patients with polymerase chain reaction tests and ground-glass opacities on computed tomography were calculated. The neutrophil/lymphocyte ratios of polymerase chain reaction-negative patients with computed tomography images were compared with the neutrophil/lymphocyte ratios of polymerase chain reaction-positive patients with computed tomography images. Results: A total of 631 patients were included in this study. Thorax computed tomography scans were obtained from all patients. The mean neutrophil/lymphocyte ratio of patients with ground-glass opacities was 3.50 +/- 2.12, whereas that of patients without ground-glass opacities was 2.90 +/- 2.01. This difference was also statistically significant. Polymerase chain reaction swab samples were obtained from 282 patients (44.7%). The mean neutrophil/lymphocyte ratio of polymerase chain reaction-positive patients was 2.38 +/- 1.02, whereas that of polymerase chain reaction-negative patients was 3.97 +/- 2.25. The difference was statistically significant. Conclusion: Many studies are undoubtedly required to determine the efficiency of the neutrophil/lymphocyte ratio in COVID-19 diagnosis. However, we postulate that evaluating the neutrophil/lymphocyte ratio along with computed tomography and polymerase chain reaction can assist in the diagnosis of patients. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.identifier.doi | 10.1177/20503121211046416 | |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | neutrophil | en_US |
dc.subject | lymphocyte ratio | en_US |
dc.subject | ground-glass opacity | en_US |
dc.subject | thorax computed tomography | en_US |
dc.subject | Pneumonia | en_US |
dc.title | Contribution of neutrophil/lymphocyte ratio to the diagnostic efficiency of computed tomography and polymerase chain reaction in COVID-19 patients | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Sage Open Medicine | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Acil Tıp Ana Bilim Dalı | en_US |
dc.authorid | 0000-0001-5879-7858 | |
dc.identifier.volume | 9 | en_US |
dc.institutionauthor | Örün, Serhat | |
dc.institutionauthor | Erdem, Mustafa Numan | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorwosid | Orun, Serhat/AAB-2040-2020 | |
dc.identifier.wos | WOS:000702271900001 | en_US |
dc.identifier.pmid | 34552748 | en_US |